M Pecherstorfer
Renal safety profiles of ibandronate 6 mg infused over 15 and 60 min: a randomized, open-label study
von Moos R, Caspar C, Thürlimann B, Angst R, Inauen R, Greil R, Bergstrom B, Schmieding K, Pecherstorfer M. Renal safety profiles of ibandronate 6 mg infused over 15 and 60 min: a randomized, open-label study. Ann Oncol 2008; 19:1266-70.
Jul 1, 2008Renal safety profiles of ibandronate 6 mg infused over 15 and 60 min: a randomized, open-label study
Jul 1, 2008Ann Oncol 2008; 19:1266-70
von Moos R, Caspar C B, Thürlimann Beat, Angst Rahel, Inauen Roman, Greil R, Bergstrom B, Schmieding K, Pecherstorfer M
Übersicht Bisphosphonate
Maschke U, Kränzlin M, Krapf R, Pecherstorfer M, Strebel U, Thürlimann B. Übersicht Bisphosphonate. Pharmakritik 2006; 28:17-20.
Jan 1, 2006Übersicht Bisphosphonate
Jan 1, 2006Pharmakritik 2006; 28:17-20
Maschke U.P., Kränzlin M, Krapf R, Pecherstorfer M, Strebel U, Thürlimann Beat
Serum parathyroid hormone-related protein levels and response to bisphosphonate treatment in hypercalcemia of malignancy
Rizzoli R, Eghbali H, Clemens M, Thürlimann B, Degardin M, Steinhauer E, Tubiana-Hulin M, Manegold C, Rückert F, Huss H, Herrmann Z, Pecherstorfer M, Bundred N, Thiébaud D, Body J. Serum parathyroid hormone-related protein levels and response to bisphosphonate treatment in hypercalcemia of malignancy. The Journal of clinical endocrinology and metabolism 1999; 84:3545-50.
Oct 1, 1999Serum parathyroid hormone-related protein levels and response to bisphosphonate treatment in hypercalcemia of malignancy
Oct 1, 1999The Journal of clinical endocrinology and metabolism 1999; 84:3545-50
Rizzoli R, Eghbali H, Clemens M R, Thürlimann Beat, Degardin M, Steinhauer E U, Tubiana-Hulin M, Manegold C, Rückert F, Huss H J, Herrmann Z, Pecherstorfer M, Bundred N, Thiébaud D, Body J J
Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancy
Pecherstorfer M, Huss H, van Eijkeren M, Steinhauer E, Tubiana-Hulin M, Thürlimann B, Clemens M, Degardin M, Manegold C, Body J, Herrmann Z, Thiébaud D. Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996; 14:268-76.
Jan 1, 1996Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancy
Jan 1, 1996Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996; 14:268-76
Pecherstorfer M, Huss H J, van Eijkeren M, Steinhauer E U, Tubiana-Hulin M, Thürlimann Beat, Clemens M R, Degardin M, Manegold C, Body J J, Herrmann Z, Thiébaud D